Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 15 of 21 items.

Health alert or recall Health Canada warns about certain hand sanitizers that may pose health risks (Part 2 – March 31, 2021 to present)
… hand sanitizers Issue Health products - Product safety COVID What to do Stop using the identified product lots … printed on the label Product recalled by company 2021-04-19 Sani-Derm May contain unacceptable ingredient, ethyl … seek medical help immediately. To help limit the spread of COVID-19, wash your hands often with soap and water for at …
AlertPublic advisory | 2022-07-11
Health alert or recall COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
… (the Canadian importer and distributor) is distributing COVID-19 Vaccine Moderna doses directly to vaccination locations … and public health authorities. Key messages The COVID-19 Vaccine Moderna (mRNA-1273 SARS-CoV-2 vaccine) …
AlertHealth professional risk communication | 2021-02-22
Health alert or recall Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
… (POUs). Pfizer is initially distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination locations … Key messages On December 9, 2020, Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02509210) was …
AlertHealth professional risk communication | 2020-12-12
Health alert or recall Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
… Sale and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered together, … treatment of mild to moderate coronavirus disease 2019 (COVID-19), confirmed by direct SARS-CoV-2 viral testing, in …
AlertHealth professional risk communication | 2021-07-30
Health alert or recall Fraudulent and unauthorized N95 respirators may not protect consumers against COVID-19
… N95 respirators, as they may not protect consumers against COVID-19. What to do: Check whether your N95 respirator has been … stop using it as it may not protect you against COVID-19. What you should do Media enquiries Public enquiries …
AlertPublic advisory | 2020-04-14
Health alert or recall Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
… Sale and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of adults … patients 12 years of age or older with mild to moderate COVID-19, who weigh at least 40 kg and who are at high risk …
AlertHealth professional risk communication | 2020-12-18
Health alert or recall Archived – Medication Errors Involving Reminyl and Amaryl – Janssen-Ortho Inc. and Aventis Pharma Inc.
… Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … Care Professional: Please be aware of the following: Janssen-Ortho Inc. and Aventis Pharma Inc. (collectively, … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, OntarioM3C 1L9 Call toll-free at …
AlertHealth professional risk communication | 2004-12-21
Health alert or recall Archived – Medication Errors Involving Reminyl and Amaryl –Janssen-Ortho Inc. and Aventis Pharma Inc.
… Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … ® Dear Pharmacist: Please be aware of the following: Janssen-Ortho Inc. and Aventis Pharma Inc. (collectively, … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Call toll-free …
AlertHealth professional risk communication | 2004-12-21
Health alert or recall Archived - Drug Release Information for the EVRA Transdermal Contraceptive System - For the Public
… Starting date: March 19, 2009 Posting date: March 19, 2009 Type of communication: … RA-19000741 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … Footnote * Birth Control Patch Average Daily Release Rate Janssen-Ortho Inc., in cooperation with Health Canada, is …
AlertHealth professional risk communication | 2009-03-19
Health alert or recall Archived – New Safety Information Regarding Intelence (etravirine) and Severe Skin and Hypersensitivity Reactions – For the Public
… Starting date: October 19, 2009 Posting date: October 19, 2009 Type of … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc . Contact the company for a copy of any … Severe Skin and Allergic Reactions Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …
AlertHealth professional risk communication | 2009-10-19
Health alert or recall Risperdal Consta (risperidone powder for injectable prolonged-release suspension) – Needle Detachments Associated with the Needle Assembly Used for Gluteal Injection
… Images This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … powder for Injectable Prolonged-Release Suspension Janssen-Ortho, in cooperation with Health Canada, would like … Janssen-Ortho Inc. Medical Information Department 19 Green Belt Drive Toronto, Ontario  M3C 1L9 Telephone: …
AlertHealth professional risk communication | 2010-05-25
Health alert or recall Archived - PREPULSID (cisapride)
… effective August 7, 2000. PREPULSID, marketed by Janssen-Ortho Inc., is a prescription drug indicated for the … outweigh the risk of serious cardiac adverse events. Janssen-Ortho Inc. has indicated to Health Canada that it … The Special Access Programme is prepared to authorize Janssen- Ortho to release PREPULSID for these patients. …
AlertHealth professional risk communication | 2000-05-30
Health alert or recall Archived – Important Drug Safety Information: Risperdal (Risperidone) and Cerebrovascular Adverse Events in Placebo-Controlled Dementia Trials – Janssen-Ortho Inc.
… RA-17000390 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … Dementia Trials Dear Healthcare Professional: Janssen-Ortho Inc., following discussions with Health Canada, … USA-63 1% (5/462) 1% (2/163) BEL-14 0% (0/20) 0% (0/19) Total 4% (29/764) 2% (7/466) Four patients died in the …
AlertHealth professional risk communication | 2002-10-11
Health alert or recall Archived – Medication Errors Involving REMINYL and AMARYL® – Janssen-Ortho Inc. and Aventis Pharma Inc.
… RA-19000210 This is duplicated text of a letter from Janssen-Ortho Inc. and Aventis Pharma Inc. Contact the … and AMARYL ® (glimepiride). Toronto, December 21, 2004 - Janssen-Ortho Inc. and Aventis Pharma Inc., (collectively, … Canada at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Or call toll …
AlertHealth professional risk communication | 2004-12-21
Health alert or recall Archived - Association of PREZISTA (darunavir) with hepatotoxicity
… RA-19000676 This is duplicated text of a letter from Janssen-Ortho Inc . Contact the company for a copy of any … and serious liver side effects Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in cooperation with Health … a division of Janssen-Ortho Inc. Drug Safety Department 19 Green Belt Drive Toronto, ON M3C 1L9 Tel: 800-567-3331 or …
AlertHealth professional risk communication | 2008-05-15
Report a problem or mistake on this page
What was wrong?

You will not receive a reply. Telephone numbers and e-mail addresses will be removed.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.